Multiplex immunofluorescence as our method of choice accurately quantifies CD3+ and CD8+ cells in specific regions of the tumor microenvironment and is superior to HE-based TIL evaluation or single-target immunohistochemistries (3, 15, 16). Here, CD8A is linked to neoplasm.